Be Prepared: Transitioning Certain OTC Antimicrobial Products to Rx June 2023

Mar 24, 2023

FDA published Guidance for Industry (GFI) #263 in June 2021 which outlined a plan for transitioning certain over-the-counter (OTC) antimicrobial products for animals to prescription (Rx) status. As outlined in FDA's Guidance for Industry (GFI) #263, FDA expects approved animal drug products containing medically important antimicrobials that are currently available as OTC products to transition to Rx status beginning in June 2023. To help prepare for this transition, FDA Center for Veterinary Medicine (CVM) is conducting outreach to increase awareness about this expected change.

FDA CVM has developed written materials with information on products/indications that will be transitioning as part of GFI 263 and information on how interested animal owners can locate a vet. Also linked below are a brochure and poster which detail the importance of veterinary involvement as products transition to Rx.

Click here to see more...

Video: What Drives Profitability in Farrowing? - Dr. Daniel Gascho

In this special episode of The Swine it Podcast Show Canada, marking World Veterinary Day, we welcome Dr. Daniel Gascho, swine production veterinarian and partner at Four Star Veterinary Service. He discusses how farrowing decisions must align with each farm's business model, why labor execution defines protocol outcomes, and how PRRS strategies should be tailored to each operation's health status and market position. Listen now on all major platforms!

"Protocols are only as strong as the labor that executes them, and that final step is what separates a plan on paper from results in the barn."

Meet the guest: Dr. Daniel Gascho / daniel-gascho-4a1bbb242 is a swine production medicine veterinarian and partner at Four Star Veterinary Service, based in Indiana. He focuses on individualized health strategies, vaccination planning, biosecurity, and practical protocol implementation across farrowing, nursery, and grow-finish systems.